Skip to main content

Advertisement

Table 1 Baseline parameters of Fluocinolone Acetonide implant treated eyes

From: Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting

Parameter Value
Visual Acuity (ETDRS letters) Range (2–85), Mean (50.7)
Central Retinal Thickness (Micrometers) Range (373–1052) .Mean (631)
Duration of DMO(Months) Range (9-47). Mean (26.2)
Foveal eversion 21
Pseudophakia 22
Eyes with one co-existing pathology ERM(n = 11)
VMT(n = 2)
Glaucoma/Ocular hypertension (n = 4)
NVD n = 1
NVE n = 1
Eyes with >1 co-existing pathologies 3
Eyes on IOP lowering drugs 4
Eyes with prior macular laser only 15
Eyes with prior vitrectomy for DMO/ERM 1
Eyes with prior intravitreal therapy Ranibizumab only– n = 11
Bevacizumab only n = 2
Rani and Beva n = 3
Triamcinolone n = 6
Eyes with prior PRP 9